NEW YORK, Feb. 15, 2012 /PRNewswire/ -- The Lupus Research Institute (LRI) today awards 12 "Novel Research Grants" to jumpstart discovery in lupus by supporting original, highly promising ideas from some of the country's most creative scientists. Studies will look at why lupus turns the body's immune system against itself and pioneer strategies for new treatment development.
The new awards represent diverse disciplines, from inflammation and medical imaging to evolutionary biology and the emerging field of epigenetics, bringing new talent and new approaches to lupus. Rigorous peer-review of 106 applications involved LRI's scientific advisors and over 90 lupus experts nationwide; $3.6 million was granted. Award-winning projects represent the best of the best, with potential to achieve significant results and accelerate drug discovery.
"What distinguishes the Lupus Research Institute is our insistence on funding only novel ideas rather than furthering established concepts," said Margaret Dowd, LRI President and CEO. "Our success in delivering pivotal discoveries proves that openness to inventive science works. As one advisor eloquently noted, 'great science cannot be managed; it must be imagined.'"
Championing human lupus biology, the LRI aims to speed the pace of meaningful findings in the human disease, providing fresh insights to directly inform new treatment and diagnostic development. Six investigators will work directly with patients using their blood cells, genetic information, and brain images to ask fundamental questions about the lupus immune system previously only approached in animal models.
"The Lupus Research Institute is uniquely positioned to identify novel high-risk projects that offer great return for the lupus community," noted world-leading immunologist Dr. William Paul, LRI Scientific Advisory Board Chairman and Nati
|SOURCE Lupus Research Institute|
Copyright©2010 PR Newswire.
All rights reserved